Featured 13F manager
Egerton Capital (UK) LLP John Armitage
London, X0 23 processed 13Fs on this site · 2021 Q3–2026 Q2
- $10.4B
- 23 Positions
- 2026 Q2
- +14.9% QoQ
- Top 5 49.3%
Portfolio
top 5 49.3% · top 10 76.0%
- V - VISA · CL A 14.1%
- GOOG - Alphabet · CL C 11.2%
- APH - Amphenol · CL A 8.3%
- AMZN - Amazon 8.2%
- MCO - Moodys 7.5%
- NVDA - Nvidia 6.6%
- MDLN - Medline · CL A 6.3%
- VMC - Vulcan Matls 5.6%
- CRH - CRH PLC 4.5%
- AMAT - Applied Matls 3.7%
- IBKR - Interactive Brokers · CL A 3.5%
- DVN - Devon Energy 3.0%
- Other 17.5%
AUM over time
Book
| V - VISA · CL A | 13.79% | Add +25.7% | 4,110,970 | $302.24 | $1.2B | +839,971 | +$95M |
| GOOG - Alphabet · CL C | 11.01% | Add +220.7% | 3,459,649 | $286.86 | $992M | +2,380,881 | +$654M |
| MCO - Moodys | 7.48% | Add +99.9% | 1,545,670 | $436.25 | $674M | +772,261 | +$279M |
| LIN - Linde | 5.88% | New | 1,068,371 | $495.76 | $530M | +1,068,371 | +$530M |
| CRS - Carpenter Technology | 5.82% | Reduce −14.3% | 1,330,920 | $394.15 | $525M | −222,092 | +$36M |
| AMZN - Amazon | 5.46% | Reduce −59.9% | 2,363,334 | $208.27 | $492M | −3,529,162 | −$868M |
| VMC - Vulcan Matls | 5.35% | Add +84.3% | 1,769,216 | $272.30 | $482M | +809,043 | +$208M |
| NVDA - Nvidia | 5.18% | New | 2,675,018 | $174.40 | $467M | +2,675,018 | +$467M |
| IBKR - Interactive Brokers · CL A | 4.67% | Reduce −9.6% | 6,275,179 | $67.07 | $421M | −664,402 | −$25M |
| APH - Amphenol · CL A | 4.03% | Reduce −22.6% | 2,871,353 | $126.35 | $363M | −836,558 | −$138M |
| CME - CME Group | 3.88% | Add +0.3% | 1,182,907 | $295.35 | $349M | +3,115 | +$27M |
| UBER - UBER Technologies | 3.71% | Add +73.5% | 4,652,363 | $71.93 | $335M | +1,971,191 | +$116M |
| DVN - Devon Energy | 3.64% | New | 6,525,140 | $50.32 | $328M | +6,525,140 | +$328M |
| CRH - CRH PLC | 3.22% | Add +22.0% | 2,759,331 | $105.12 | $290M | +498,271 | +$8M |
| CNQ - Canadian Natural | 3.07% | New | 5,690,211 | $48.69 | $277M | +5,690,211 | +$277M |
| MA - Mastercard · CL A | 2.55% | Add +0.3% | 459,652 | $499.66 | $230M | +1,310 | −$32M |
| MDLN - Medline · CL A | 2.16% | New | 4,365,802 | $44.50 | $194M | +4,365,802 | +$194M |
| ERJ - Embraer S a | 1.96% | Reduce −9.2% | 2,975,231 | $59.34 | $177M | −302,909 | −$34M |
| FERG - Ferguson Enterprises | 1.64% | Reduce −37.1% | 634,258 | $233.26 | $148M | −374,056 | −$77M |
| LAMR - Lamar Advertising · CL A | 1.53% | Add +50.8% | 1,088,744 | $126.66 | $138M | +366,661 | +$46M |
| ACGL - Arch Cap Group | 1.19% | New | 1,116,922 | $95.99 | $107M | +1,116,922 | +$107M |
| RNR - Renaissancere | 1.05% | Reduce −35.3% | 317,308 | $297.23 | $94M | −173,318 | −$44M |
| NYT - New York Times · CL A | 0.90% | Reduce −31.1% | 971,884 | $83.73 | $81M | −438,119 | −$17M |
| AWI — | 0.82% | New | 448,036 | $164.80 | $74M | +448,036 | +$74M |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2025 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| MSFT - Microsoft | 9.19% | Exit | 0 | $483.62 | $846M | −1,748,656 | −$846M |
| BSX - Boston Scientific | 5.58% | Exit | 0 | $95.35 | $513M | −5,385,084 | −$513M |
| COF - Capital One Finl | 5.45% | Exit | 0 | $242.36 | $501M | −2,069,130 | −$501M |
| WYNN - Wynn Resorts | 2.71% | Exit | 0 | $120.33 | $249M | −2,069,751 | −$249M |
| STX - Seagate | 2.18% | Exit | 0 | $275.39 | $201M | −729,325 | −$201M |
| LPLA - Lpl Finl | 0.99% | Exit | 0 | $357.17 | $91M | −254,813 | −$91M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 23 | $10.4B | +14.9% | 13F-HR | 7/21/2026 | 000158181126000007 |
| 2026 Q1 | 24 | $9B | −2.1% | 13F-HR | 5/13/2026 | 000158181126000005 |
| 2025 Q4 | 23 | $9.2B | −3.0% | 13F-HR | 2/11/2026 | 000158181126000002 |
| 2025 Q3 | 24 | $9.5B | −2.7% | 13F-HR | 11/12/2025 | 000158181125000010 |
| 2025 Q2 | 25 | $9.7B | +12.5% | 13F-HR | 8/12/2025 | 000158181125000007 |
| 2025 Q1 | 27 | $8.7B | +0.2% | 13F-HR | 5/6/2025 | 000158181125000005 |
| 2024 Q4 | 30 | $8.6B | −12.7% | 13F-HR | 2/10/2025 | 000158181125000004 |
| 2024 Q3 | 30 | $9.9B | +0.1% | 13F-HR | 11/5/2024 | 000158181124000009 |
| 2024 Q2 | 26 | $9.9B | −4.3% | 13F-HR | 8/13/2024 | 000158181124000007 |
| 2024 Q1 | 22 | $10.3B | +12.1% | 13F-HR | 5/13/2024 | 000158181124000004 |
| 2023 Q4 | 22 | $9.2B | +7.1% | 13F-HR | 2/12/2024 | 000158181124000003 |
| 2023 Q3 | 22 | $8.6B | −11.2% | 13F-HR | 11/13/2023 | 000158181123000006 |
| 2023 Q2 | 23 | $9.7B | +4.7% | 13F-HR | 8/10/2023 | 000158181123000005 |
| 2023 Q1 | 25 | $9.3B | −20.3% | 13F-HR | 5/9/2023 | 000158181123000004 |
| 2022 Q4 | 21 | $11.6B | −9.8% | 13F-HR | 2/7/2023 | 000158181123000002 |
| 2022 Q3 | 23 | $12.9B | −13.1% | 13F-HR | 11/10/2022 | 000158181122000008 |
| 2022 Q2 | 26 | $14.8B | −21.9% | 13F-HR | 8/9/2022 | 000158181122000007 |
| 2022 Q1 | 29 | $19B | — | RESTATEMENT | 8/3/2022 | 000091957422004541 |
| 2022 Q1 | 29 | $19B | −11.5% | 13F-HR | 5/9/2022 | 000158181122000004 |
| 2021 Q4 | 32 | $21.4B | — | RESTATEMENT | 8/3/2022 | 000091957422004539 |
| 2021 Q4 | 32 | $21.4B | +1.9% | 13F-HR | 2/11/2022 | 000158181122000003 |
| 2021 Q3 | 34 | $21B | — | RESTATEMENT | 8/3/2022 | 000091957422004537 |
| 2021 Q3 | 34 | $21B | — | 13F-HR | 11/8/2021 | 000158181121000007 |
About
Egerton Capital (UK) LLP
23 processed 13Fs on this site · 2021 Q3–2026 Q2